✦ LIBER ✦

WS1.1 Liver disease in cystic fibrosis

✍ Scribed by M. Rowland; C. Gallagher; C.G. Gallagher; R. Olaoide; G. Canny; A.M. Broderick; P. Greally; D. Slattery; L. Daly; N.G. McElvaney; P. Durie; B. Bourke

Book ID: 117799343
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 64 KB
Volume: 11
Category: Article
ISSN: 1569-1993
DOI: 10.1016/s1569-1993(12)00085-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

WS5.1 Inhaled glutathione in cystic fibr

WS5.1 Inhaled glutathione in cystic fibrosis

✍ M. Griese; A. Hector; M. Kappler; M. Ballmann; S. Junge; E. Rietschel; D. Staab; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 70 KB

WS12.1 The prevalence of substance abuse

WS12.1 The prevalence of substance abuse in cystic fibrosis

✍ S. Malhotra; N. Brager; H.R. Rabin; M.D. Parkins; M. Hertzsprung; J. Leong 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 61 KB

WS24.1 Sinonasal pathology in adult pati

WS24.1 Sinonasal pathology in adult patients with cystic fibrosis

✍ M.C. Berkhout; E. Rijntjes; L.H. el Bouazzaoui; R.W. Brimicombe; C.J. van Rooden 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Outcome in Cystic Fibrosis Liver Disease

✍ M. Rowland; C. Gallagher; G. Canny; P. Greally; D. Slattery; R. Hayes; R. O'Laoi 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Cystic fibrosis-associated liver disease

✍ Ulrike Herrmann; Gerd Dockter; Frank Lammert 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 329 KB

WS20.1 Target minority bacterial populat

WS20.1 Target minority bacterial population in cystic fibrosis lung microbiota

✍ P. Sharma; N. Stremler; M. Reynaud-Gaubert; J.-C. Dubus; J.-M. Rolain 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 63 KB